New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Alto Neuroscience, Inc. (ANRO) vs Omeros Corporation (OMER)
- Alto Neuroscience, Inc. ANRO 25.37 −4.30%
- Omeros Corporation OMER 13.21 −5.71%
Alto Neuroscience, Inc. and Omeros Corporation are both Biotechnology companies. Alto Neuroscience, Inc. and Omeros Corporation are of similar size ($1.1B and $1.0B). Alto Neuroscience, Inc. has negative trailing earnings, so its P/E is not meaningful; Omeros Corporation trades at 9.5×. Across the 8 metrics below, Omeros Corporation leads on 6 and Alto Neuroscience, Inc. on 2.
Valuation
Profitability
| Metric | ANRO | OMER | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 97.27% | 70.18% |
| Operating margin | — | (232.94%) | 0.00% |
| Net margin | — | (136.61%) | 0.00% |
| Free cash flow margin | — | (121.65%) | 0.00% |
| Return on equity | (46.65%) | (63.38%) | (51.58%) |
| Return on assets | (40.20%) | 45.36% | (45.91%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack